ADR Notebook HK

ADR · 2025-12-12

What Is the Abbreviation ADR? Different Definitions Across Business, Medical, and Financial Sectors

On 30 June 2025, the Hong Kong Monetary Authority (HKMA) issued a revised Supervisory Policy Manual module on dispute resolution for the banking sector, mandating that all authorised institutions publish a clear, plain-language explanation of their internal and external Alternative Dispute Resolution (ADR) options. This regulatory shift is not an isolated event. Across Hong Kong’s commercial, medical, and financial sectors, the abbreviation “ADR” carries distinct, sector-specific meanings that can confuse litigants-in-person, HR professionals, and compliance officers. A business owner facing a contractual dispute, a patient considering a medical negligence claim, and a shareholder in a listed company all encounter “ADR” — but the procedures, forums, and legal frameworks differ fundamentally. Misunderstanding which ADR applies can result in missed deadlines, forfeited rights, or proceedings in the wrong tribunal. This article maps the three primary definitions of ADR in Hong Kong: Alternative Dispute Resolution in commercial and employment contexts, the Alternative Dispute Resolution scheme for medical claims under the voluntary pilot scheme, and American Depositary Receipts in cross-border securities. Each definition triggers a different set of rules, time limits, and regulatory bodies.

Commercial and Employment ADR: Mediation and Arbitration Under Hong Kong Law

The Statutory Framework for Mediation and Arbitration

In Hong Kong’s commercial and employment sectors, ADR stands for Alternative Dispute Resolution. The primary statutes are the Arbitration Ordinance (Cap. 609) and the Mediation Ordinance (Cap. 620). The Arbitration Ordinance provides that an arbitration agreement must be in writing (Section 19). The Mediation Ordinance establishes a framework for mediated settlement agreements, including confidentiality protections (Section 8). For employment disputes, the Labour Tribunal (Cap. 25) routinely refers cases to mediation before adjudication. The court procedure is that parties must attempt mediation before trial in the District Court or the Court of First Instance; failure to do so can result in adverse costs orders under Order 62 of the Rules of the High Court (Cap. 4A).

Step-by-Step: Initiating Commercial Mediation

Step 1: Identify whether your contract contains a dispute resolution clause specifying mediation or arbitration. If it names the Hong Kong International Arbitration Centre (HKIAC), follow its Administered Arbitration Rules. Step 2: If no clause exists, either party may propose mediation in writing. The Hong Kong Mediation Accreditation Association Limited (HKMAAL) maintains a register of accredited mediators. Step 3: The mediator facilitates negotiation but does not impose a binding decision. If settlement is reached, the parties sign a mediated settlement agreement. Under the Mediation Ordinance, this agreement is enforceable as a contract. If mediation fails, the dispute proceeds to litigation or arbitration.

Arbitration vs. Litigation: Key Differences

Arbitration under Cap. 609 is binding and final, subject only to limited appeal on a question of law (Section 69). The award is enforceable in Hong Kong as a court judgment. The District Court has jurisdiction for claims up to HK$3 million; the Court of First Instance handles claims above that threshold. The Small Claims Tribunal (Cap. 338) deals with claims up to HK$75,000. The key advantage of arbitration is confidentiality — proceedings are private, unlike open court hearings. The key disadvantage is cost: arbitrator fees can exceed court filing fees. The legislation provides that parties may agree on the number of arbitrators and the place of arbitration (Sections 23 and 24).

Medical ADR: The Pilot Scheme for Alternative Dispute Resolution in Healthcare

The Voluntary Pilot Scheme for Medical Negligence Claims

In the medical sector, ADR refers to the Alternative Dispute Resolution scheme introduced by the Food and Health Bureau in 2023 as a voluntary pilot for medical negligence claims. This scheme applies to public hospitals under the Hospital Authority and private hospitals that opt in. The scheme’s objective is to reduce litigation costs and time. Under the pilot, a patient who believes they have suffered harm due to medical treatment may apply for ADR instead of filing a writ in the Court of First Instance. The scheme does not replace the right to sue — it is an alternative pathway.

The Process: Mediation and Expert Evaluation

Step 1: The patient submits a written complaint to the hospital’s designated ADR officer within three years of the incident. Step 2: The hospital conducts an internal investigation and shares findings with the patient. Step 3: A panel comprising a medical expert and a legal professional reviews the case. The panel issues a non-binding opinion on whether the standard of care was breached. Step 4: If the opinion finds a breach, the hospital may offer compensation without admission of liability. If the patient accepts, the matter ends. If not, the patient retains the right to litigate. The scheme’s key feature is that the panel’s opinion is inadmissible in subsequent court proceedings, preserving the patient’s legal position.

Limitations and Criticisms

The pilot scheme covers only claims arising from treatment after 1 January 2023. It excludes cases involving criminal conduct, serious permanent disability, or death. As of the HKMA’s 2025 circular, only 12 private hospitals had signed up. The Hong Kong Medical Association has expressed concerns about the scheme’s voluntary nature and the lack of binding effect on hospitals. The court procedure is that if the patient rejects the panel’s opinion, they can still file a writ in the Court of First Instance within the limitation period. The legislation provides no statutory bar on subsequent litigation.

Financial ADR: American Depositary Receipts in Cross-Border Securities

The Dual Meaning of ADR in Hong Kong’s Financial Markets

In the financial sector, ADR most commonly stands for American Depositary Receipts — negotiable certificates issued by a US depositary bank representing shares in a non-US company. Hong Kong-listed companies, such as Alibaba Group Holding Limited (9988.HK), issue ADRs traded on the New York Stock Exchange or Nasdaq. The Securities and Futures Commission (SFC) regulates the offering of ADRs under the Securities and Futures Ordinance (Cap. 571). The Hong Kong Stock Exchange (HKEX) Listing Rules require disclosure of any ADR issuance in the company’s listing documents (Main Board Rule 8.07). For Hong Kong investors, ADRs provide exposure to US markets without needing a US brokerage account.

Regulatory Framework and Investor Protections

The SFC’s Code on Takeovers and Mergers applies to ADR holders if the ADRs carry voting rights. The HKMA’s 2024 circular on cross-border securities transactions requires authorised institutions to disclose whether ADRs are held in custody or as part of a structured product. Investors should note that ADR holders may not have the same shareholder rights as ordinary shareholders — for example, voting rights may be limited or absent. The court procedure for disputes involving ADRs typically involves US securities law, as the depositary bank is usually a US entity. Hong Kong courts have jurisdiction only if the ADR agreement specifies Hong Kong law. The legislation provides that the Securities and Futures Ordinance (Cap. 571) governs the offer of ADRs to the Hong Kong public.

Risks and Practical Considerations

The primary risk is currency fluctuation: ADR prices are in US dollars, while the underlying shares trade in Hong Kong dollars. The exchange rate between the two currencies affects the ADR’s value. The second risk is regulatory divergence: US Securities and Exchange Commission (SEC) rules on insider trading and disclosure differ from Hong Kong’s SFC rules. The HKEX’s 2025 annual report noted that 23 Hong Kong-listed companies had ADR programmes, representing a total market capitalisation of approximately HK$4.2 trillion. Investors should verify whether the ADR is sponsored (company-supported) or unsponsored (issued without company consent). Unsponsored ADRs carry higher risks, including lack of corporate communication.

Sector-Specific Takeaways for Practitioners

For Commercial and Employment Disputes

  1. Always check your contract for a dispute resolution clause — failure to follow the prescribed ADR mechanism can void the proceedings. 2. Mediation must be attempted before trial in the District Court or Court of First Instance; a failure to mediate risks an adverse costs order. 3. Arbitration awards under Cap. 609 are final and enforceable in Hong Kong; appeal is limited to questions of law.

For Medical Negligence Claims

  1. The ADR pilot scheme is voluntary and covers only claims from treatment after 1 January 2023 — confirm the incident date before applying. 2. The panel’s opinion is non-binding and inadmissible in court, so the patient’s right to sue is preserved. 3. Only 12 private hospitals participate as of 2025 — verify the hospital’s status before initiating the ADR process.

For Cross-Border Securities

  1. ADR holders may have limited voting rights — review the depositary agreement before purchasing. 2. Hong Kong courts have jurisdiction only if the ADR agreement specifies Hong Kong law; otherwise, US securities law applies. 3. Currency risk is inherent — monitor the USD/HKD exchange rate when valuing ADR holdings.

This does not constitute legal advice. Consult a solicitor for your specific case.